# OTLK PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/OTLK
Company: Outlook

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with OTLK.

## OTLK PDUFA Milestones

- 2026-07-29 — PDUFA — ONS-5010 / LYTENAVA™ (bevacizumab-vikg) treating Wet age-related macular degeneration (AMD)
  Company: Outlook
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/july (July 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/OTLK
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the OTLK PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with OTLK, including decision dates, application stage, and summary details when available.
### Where can I find more context for OTLK?

Use the BioPharmSignal company page for OTLK to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.